We are live on ! Find out more
TDOC icon

Teladoc Health

Positive
Neutral
Negative
Sentiment 3-Months
Positive 35.5%
Neutral 48.4%
Negative 16.1%

Neutral
Zacks Investment Research
4 days ago
Teladoc (TDOC) Rises Higher Than Market: Key Facts
Teladoc (TDOC) closed the most recent trading day at $9.21, moving +1.54% from the previous trading session.
Teladoc (TDOC) Rises Higher Than Market: Key Facts
Neutral
Benzinga
6 days ago
Teladoc in the Spotlight as Investors Refocus on Company's Walmart Better Care Partnership
Teladoc Health Inc. (NYSE:TDOC) shares are trending Wednesday as investors take a fresh look at the company.
Teladoc in the Spotlight as Investors Refocus on Company's Walmart Better Care Partnership
Positive
The Motley Fool
7 days ago
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?
Hims & Hers Health continues to drive impressive growth through its subscription-based consumer wellness platform. Teladoc Health maintains a dominant market share with over 100 million global members and significant institutional partnerships.
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?
Neutral
GlobeNewsWire
11 days ago
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
Positive
The Motley Fool
11 days ago
Teladoc's Recovery Story Is Starting to Take Shape. Should You Buy the Stock?
Teladoc's business is slowly improving due to several initiatives. However, the company still faces potential headwinds that could derail its progress.
Teladoc's Recovery Story Is Starting to Take Shape. Should You Buy the Stock?
Negative
Zacks Investment Research
13 days ago
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw Teladoc (TDOC) settling at $8.48, representing a -2.42% change from its previous close.
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know
Positive
Zacks Investment Research
15 days ago
Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last?
Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last?
Neutral
PRNewsWire
15 days ago
SenesTech Appoints Jack Karabees as Executive Vice President of Sales
Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizations SURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, today announced the appointment of Jack Karabees as Executive Vice President of Sales.
SenesTech Appoints Jack Karabees as Executive Vice President of Sales
Neutral
Zacks Investment Research
19 days ago
Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note
Teladoc (TDOC) concluded the recent trading session at $7.81, signifying a +1.56% move from its prior day's close.
Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note
Positive
MarketBeat
24 days ago
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
The GLP-1 revolution is quietly continuing even as investor interest has moved on to more timely topics. One of the best ways to access the fast-growing weight loss drug space is via makers like Novo Nordisk NYSE: NVO or Eli Lilly NYSE: LLY, the leading companies responsible for developing and manufacturing products like Ozempic and Zepbound.
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend